$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
瑞宁得效果怎样?
2025-10-19 11:44:20
Check Details
阿培利司(阿尔卑利昔)纳入医保了吗?
2025-10-19 11:44:20
Check Details
阿培利司(阿博利布)上市了吗?
2025-10-19 11:44:20
Check Details
瑞宁得疗效如何?
2025-10-19 11:44:20
Check Details
瑞宁得中国上市了吗?
2025-10-19 11:44:20
Check Details
瑞宁得获批适应症有什么?
2025-10-19 11:44:20
Check Details
瑞宁得进医保了吗?
2025-10-19 11:44:20
Check Details
瑞宁得(anastrozol)中文说明书
2025-10-19 11:44:20
Check Details
瑞宁得(anastrozol)注意事项
2025-10-19 11:44:20
Check Details
瑞宁得(阿那曲唑)价格
2025-10-19 11:44:20
Check Details
阿培利司再次获批,用于PIK3CA突变乳腺癌!
2025-10-19 11:44:20
Check Details
三阴性乳腺癌:紫杉醇联合卡铂治疗是一种有效的辅助化疗选择
2025-10-19 11:44:20
Check Details
1
2
...
1867
1868
1869
1870
1871
1872
1873
...
4157
4158
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
2
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
3
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
4
Cabozantinib Capsules: A Multi-Targeted Therapy for Progressive Medullary Thyroid Cancer
5
Lorlatinib: Mechanism, Advantages, and Key Considerations of Third-Generation ALK Inhibitor Therapy in ALK-Positive NSCLC
6
Pemigatinib Side Effects Explained: Managing Adverse Reactions of FGFR-Targeted Therapy in Cholangiocarcinoma
7
Selpercatinib: Before or After Meals? A Complete Guide to RET-Targeted Therapy Administration
8
Mitotane for Adrenocortical Carcinoma: Dosing Guidelines and Therapeutic Drug Monitoring
9
Leflunomide and Ocular Adverse Effects: Risk Awareness and Clinical Guidance
10
Clinical Management of Acquired Resistance to Garsorasib (KRAS G12C Inhibitor)
11
Chemical Structure of Capivasertib: A Novel AKT Inhibitor
12
Capivasertib: An AKT Inhibitor for Breast and Prostate Cancer